A health awareness and educational initiative focused on schistosomiasis, aimed at both affected migrant communities and healthcare professionals. Its goal is to improve early detection and diagnosis of the disease. Activity subsidized by the Ministry of Social Rights, Consumer Affairs and Agenda 2030, funded through the tax allocation of Personal Income Tax (IRPF) and Corporate Income Tax (0.7% grants)

Schistosomiasis is an infectious disease that affects 250 million people worldwide. Through the SchistoSTOP study, we intend on screening the population from sub-Saharan African countries, which is where this infection has a greater prevalence, but also people who travel to endemic countries, with the aim of identifying those who are living with schistosomiasis and offering them treatment.

Tuberculosis is still a global public health problem affecting millions of people worldwide, predominantly in low- and middle-income countries. We have carried out a thorough study of the cases, allowing us to conclude that the main problem detected is a very significant diagnostic delay in a pandemic context.